Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells
Publication date:
2014
Editorial:
Hindawi Publishing Corporation
Publisher version:
Citación:
BioMed Research International, 2014 (2014); doi:10.1155/2014/265840
DOI:
Patrocinado por:
This work was supported by the Spanish grants of Fondo de Investigaciones Sanitarias (Instituto Carlos III) PS09/00420 and PI12/01280 and by the Celgene Corporation.
Id. Proyecto:
PS09/00420
PI12/01280
Collections
- Artículos [33266]
- Biología Funcional [680]
- Investigaciones y Documentos OpenAIRE [6800]
Files in this item
